UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 390

Sortiert nach

Rivastigmine-induced REM sleep behavior disorder (RBD) in a 88-year-old man with Alzheimer's disease

Journal of clinical sleep medicine, 2010-04, Vol.6 (2), p.192-195

2010

Link zum Volltext

Verfügbarkeit prüfen

Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS‐CoV‐2

Journal of medical virology, 2020-06, Vol.92 (6), p.595-601

2020

Link zum Volltext

Verfügbarkeit prüfen

Distinct in vitro and in vivo neutralization profiles of monoclonal antibodies elicited by the receptor binding domain of the ancestral SARS‐CoV‐2

Journal of medical virology, 2023-03, Vol.95 (3), p.e28673-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS

Cell, 2020-08, Vol.182 (3), p.722-733.e11

2020

Link zum Volltext

Verfügbarkeit prüfen

Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses

Immunity (Cambridge, Mass.), 2020-12, Vol.53 (6), p.1315-1330.e9

2020

Link zum Volltext

Verfügbarkeit prüfen

Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection

The Journal of infectious diseases, 2021-02, Vol.223 (2), p.197-205

2021

Link zum Volltext

Verfügbarkeit prüfen

Probing the binding nature and stability of highly transmissible mutated variant alpha to omicron of SARS‐CoV‐2 RBD with ACE2 via molecular dynamics simulation

Journal of cellular biochemistry, 2023-08, Vol.124 (8), p.1115-1134

2023

Link zum Volltext

Verfügbarkeit prüfen

Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection

Journal of biomedical science, 2022-01, Vol.29 (1), p.1-1, Article 1

2022

Link zum Volltext

Verfügbarkeit prüfen

Determinants of protection against SARS‐CoV‐2 Omicron BA.1 and Delta infections in fully vaccinated outpatients

Journal of medical virology, 2023-08, Vol.95 (8), p.e28984-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Neutralizing Aptamers Block S/RBD‐ACE2 Interactions and Prevent Host Cell Infection

Angewandte Chemie (International ed.), 2021-04, Vol.60 (18), p.10273-10278

International ed. in English, 2021

Link zum Volltext

Verfügbarkeit prüfen

Mutations of SARS-CoV-2 RBD May Alter Its Molecular Structure to Improve Its Infection Efficiency

Biomolecules (Basel, Switzerland), 2021-08, Vol.11 (9), p.1273

2021

Link zum Volltext

Verfügbarkeit prüfen

Antibody response after two doses of homologous or heterologous SARS‐CoV‐2 vaccines in healthcare workers at health promotion centers: A prospective observational study

Journal of medical virology, 2022-10, Vol.94 (10), p.4719-4726

2022

Link zum Volltext

Verfügbarkeit prüfen

Interactions of Spike-RBD of SARS-CoV-2 and Platelet Factor 4: New Insights in the Etiopathogenesis of Thrombosis

International journal of molecular sciences, 2021-08, Vol.22 (16), p.8562

2021

Link zum Volltext

Verfügbarkeit prüfen

Third dose of SARS‐CoV2 mRNA vaccination produces robust persistent cellular and humoral immune responses in liver transplant recipients

Liver international, 2023-05, Vol.43 (5), p.1120-1125

2023

Link zum Volltext

Verfügbarkeit prüfen

Cross-species recognition of SARS-CoV-2 to bat ACE2

Proceedings of the National Academy of Sciences - PNAS, 2021-01, Vol.118 (1), p.1

2021

Link zum Volltext

Verfügbarkeit prüfen

Pseudoephedrine and its derivatives antagonize wild and mutated severe acute respiratory syndrome‐CoV‐2 viruses through blocking virus invasion and antiinflammatory effect

Phytotherapy research, 2021-10, Vol.35 (10), p.5847-5860

2021

Link zum Volltext

Verfügbarkeit prüfen

Systemic effects of missense mutations on SARS-CoV-2 spike glycoprotein stability and receptor-binding affinity

Briefings in bioinformatics, 2021-03, Vol.22 (2), p.1239-1253

2021

Link zum Volltext

Verfügbarkeit prüfen

In vitro data suggest that Indian delta variant B.1.617 of SARS‐CoV‐2 escapes neutralization by both receptor affinity and immune evasion

Allergy (Copenhagen), 2022-01, Vol.77 (1), p.111-117

2022

Link zum Volltext

Verfügbarkeit prüfen

Comparison of antibody immune responses between BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in naïve and previously infected individuals

Journal of travel medicine, 2021-12, Vol.28 (8)

2021

Link zum Volltext

Verfügbarkeit prüfen

Identification of potential plant bioactive as SARS-CoV-2 Spike protein and human ACE2 fusion inhibitors

Computers in biology and medicine, 2021-09, Vol.136, p.104631-104631, Article 104631

2021

Link zum Volltext

Verfügbarkeit prüfen

Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex

International journal of molecular sciences, 2022-09, Vol.23 (17), p.10091

2022

Link zum Volltext

Verfügbarkeit prüfen

Development of variant‐proof severe acute respiratory syndrome coronavirus 2, pan‐sarbecovirus, and pan‐β‐coronavirus vaccines

Journal of medical virology, 2023-01, Vol.95 (1), p.e28172-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Optical Biosensor for the Detection of Infectious Diseases Using the Copolymer F8T2 with Application to COVID-19

Sensors (Basel, Switzerland), 2022-07, Vol.22 (15), p.5673

2022

Link zum Volltext

Verfügbarkeit prüfen

Structural bases for the higher adherence to ACE2 conferred by the SARS‐CoV‐2 spike Q498Y substitution

Acta crystallographica. Section D, Biological crystallography., 2022-09, Vol.78 (9), p.1156-1170

2022

Link zum Volltext

Verfügbarkeit prüfen

Antibodies and Vaccines Target RBD of SARS-CoV-2

Frontiers in molecular biosciences, 2021-04, Vol.8, p.671633-671633

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 390

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(384)
Mit Volltextzugriff
(385)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(378)
Severe Acute Respiratory Syndrome Coronavirus 2
(372)
Life Sciences & Biomedicine
(356)
Covid-19
(296)
Sars-Cov-2
(278)
Coronaviruses
(272)
Proteins
(264)
Antibodies
(230)
Covid-19 Vaccines
(188)
Vaccines
(180)
Humans
(163)
Viral Diseases
(158)
Rbd
(148)
Pandemics
(145)
Infections
(143)
Viruses
(138)
Spike Protein
(129)
Severe Acute Respiratory Syndrome
(128)
Immunology
(122)
Angiotensin-Converting Enzyme 2
(121)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Vaccines
(64)
Viruses
(33)
International Journal Of Molecular Sciences
(28)
Vaccine
(24)
Journal Of Medical Virology
(18)
Computers In Biology And Medicine
(10)
Biomedicines
(7)
Molecules
(7)
Diagnostics
(5)
Pathogens
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Rivastigmine-induced REM sleep behavior disorder (RBD) in a 88-year-old man with Alzheimer's disease

Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS‐CoV‐2

Distinct in vitro and in vivo neutralization profiles of monoclonal antibodies elicited by the receptor binding domain of the ancestral SARS‐CoV‐2

A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS

Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses

Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Probing the binding nature and stability of highly transmissible mutated variant alpha to omicron of SARS‐CoV‐2 RBD with ACE2 via molecular dynamics simulation

Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection

Determinants of protection against SARS‐CoV‐2 Omicron BA.1 and Delta infections in fully vaccinated outpatients

Neutralizing Aptamers Block S/RBD‐ACE2 Interactions and Prevent Host Cell Infection

Mutations of SARS-CoV-2 RBD May Alter Its Molecular Structure to Improve Its Infection Efficiency

Antibody response after two doses of homologous or heterologous SARS‐CoV‐2 vaccines in healthcare workers at health promotion centers: A prospective observational study

Interactions of Spike-RBD of SARS-CoV-2 and Platelet Factor 4: New Insights in the Etiopathogenesis of Thrombosis

Third dose of SARS‐CoV2 mRNA vaccination produces robust persistent cellular and humoral immune responses in liver transplant recipients

Cross-species recognition of SARS-CoV-2 to bat ACE2

Pseudoephedrine and its derivatives antagonize wild and mutated severe acute respiratory syndrome‐CoV‐2 viruses through blocking virus invasion and antiinflammatory effect

Systemic effects of missense mutations on SARS-CoV-2 spike glycoprotein stability and receptor-binding affinity

In vitro data suggest that Indian delta variant B.1.617 of SARS‐CoV‐2 escapes neutralization by both receptor affinity and immune evasion

Comparison of antibody immune responses between BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in naïve and previously infected individuals

Identification of potential plant bioactive as SARS-CoV-2 Spike protein and human ACE2 fusion inhibitors

Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex

Development of variant‐proof severe acute respiratory syndrome coronavirus 2, pan‐sarbecovirus, and pan‐β‐coronavirus vaccines

Optical Biosensor for the Detection of Infectious Diseases Using the Copolymer F8T2 with Application to COVID-19

Structural bases for the higher adherence to ACE2 conferred by the SARS‐CoV‐2 spike Q498Y substitution

Antibodies and Vaccines Target RBD of SARS-CoV-2

Suchergebnisse filtern